← Cockpit
AI_031predictionBiotech/Longevity100-years-biology

AGI will be defined by its ability to autonomously formulate novel scientific hypotheses — effectively solving '100 years of biology' in a fraction of the historical time required, via continuous hypothesis-generation and experimental iteration.

Predictor: Demis Hassabis

Prior probability
60.0%
Current probability
51.2%
evolves via intake + LBP
Conviction
4/5
Signal quality
A
Resolution
in_progress
Window
2030-01-01 – 2040-11-30
Edges in / out
6 / 0
Tickers exposed
0

Prediction text

AGI will be defined by its ability to autonomously formulate novel scientific hypotheses — effectively solving '100 years of biology' in a fraction of the historical time required, via continuous hypothesis-generation and experimental iteration. | First Isomorphic Labs approved drug from AI-designed molecule

Key catalyst: First Isomorphic Labs approved drug from AI-designed molecule

Watch events: Isomorphic drug pipeline; wet-lab automation milestones

Resolution evidence

Status: in_progress

AlphaFold 3, Isomorphic Labs, Atomic AI, Cradle all accelerating biology cycles; AlphaProteo de-novo protein design 2024; GNoME materials discovery.

Predictor: Demis Hassabis

κ + Brier as of 2026-05-22
κ (discount)
0.583
Brier
0.0064
excellent
Hits / Misses
1 / 0
of 1 resolved
Hit rate
100.0%
Calibration plot (stated vs observed)

Evidence about this node from Demis Hassabis is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class: agi_breakthrough_5y

Linked via embedding similarity 0.565

Major capability discontinuity (e.g. AGI by named target year, 5-year horizon)

Base rate
20.0%
1/5 historical
Inside weight
Outside weight
no pull
inside 51.2% → blend 51.2% 0.0pp)

Tetlock-style outside view: at TRF=1 (just predicted), outside view dominates (w_in=0.3). At TRF=0 (deadline), inside view dominates (w_in=1.0). The blend regularizes overconfident inside views toward the historical base rate.

Probability over time

7 prob_history rows
0%25%50%75%100%prior 60%2026-04-302026-04-302026-05-17
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 51.2%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 11 pending
  1. 2026-06-01 → 2027-06-30pendingIsomorphic Labs files first IND for AI-designed oncology drug
    How: FDA IND acceptance and ClinicalTrials.gov registration of first Isomorphic Labs-originated oncology candidate, confirming the (revised) end-2026 Davos timeline
    Source: https://www.clinicaltrialsarena.com/news/isomorphic-labs-prepares-trials-ai-designed-drugs/conf 80%
  2. 2026-12-01 → 2028-06-30pendingIsomorphic Labs Phase 1 first-in-human dose administered for AI-designed cancer drug
    How: Isomorphic Labs press release or peer-reviewed publication confirms first patient dosed in Phase 1 trial of AI-designed (de novo molecule) oncology compound
    Source: https://creati.ai/ai-news/2026-02-14/deepmind-ai-cancer-drug-clinical-trials-2026-demis-hassabis/conf 70%
  3. 2027-01-01 → 2029-12-31pendingIsomorphic Labs / DeepMind reports drug discovery cycle time reduction below 12 months for at least one program
    How: Peer-reviewed publication or Isomorphic disclosure shows hit-to-IND time under 12 months (vs. industry average 4-6 years) for at least one program, demonstrating Hassabis 'weeks not years' framing in practice
    Source: https://www.isomorphiclabs.com/our-techconf 55%
  4. 2029-03-31pendingScenario fires: AGI mid: Kurzweil 2029 path
  5. 2027-06-01 → 2032-12-31pendingFirst peer-reviewed publication where AI system autonomously formulates and validates a novel scientific hypothesis (no targeted prompting)
    How: Nature, Science, or Cell publication where AI system (DeepMind, Anthropic, OpenAI, Meta) is credited as primary author or hypothesis-generator for novel result in biology or chemistry, with experimental validation
    Source: https://fortune.com/article/demis-hassabis-deepmind-artificial-intelligence-google-alphabet-drug-discovery-isomorphic/conf 50%
  6. 2031-12-05pendingQ1 window check-in (25%)
  7. 2030-01-01 → 2034-12-31pendingFirst AI-designed therapeutic receives FDA approval (any indication)
    How: FDA NDA/BLA approval for therapeutic where lead molecule was de novo designed by AI system (Isomorphic, Insitro, Recursion, Insilico, or similar), per FDA approval letter and company disclosure
    Source: https://www.shashi.co/2026/04/isomorphic-labs-is-about-to-find-out-if.htmlconf 50%
  8. 2030-06-01 → 2036-12-31pendingCascade: AI-driven biology research accelerates such that publication-rate compression of ~10x reported in major journal study
    How: Bibliometric study in Nature, Science, or Cell quantifies that AI-augmented biology research labs publish at ~10x the rate of pre-AI baseline, OR DeepMind reports a 'compressed century' demonstration validating Hassabis '100 years of biology' framing
    Source: https://www.newsbytesapp.com/news/science/demis-hassabis-outlines-isomorphic-labs-to-speed-drug-discovery/tldrconf 40%
  9. 2033-11-07pendingQ2 window check-in (50%)
  10. 2035-10-11pendingQ3 window check-in (75%)

No downstream cascades — this prediction is a leaf in the dependency graph.

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 51%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
LBP2026-05-17T02:00:01Z51.2%+1.5pp
Network propagation: 49.8% → 51.2%
5-iter LBP, residual 0.00689 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e607fa96
LBP2026-05-10T02:00:02Z49.8%+2.9pp
Network propagation: 46.8% → 49.8%
6-iter LBP, residual 0.00584 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run e5c18d29
LBP2026-05-03T02:00:01Z46.8%+5.7pp
Network propagation: 41.1% → 46.8%
6-iter LBP, residual 0.00677 · damping 0.5, w_intrinsic 0.5 · method lbp_v3 · run 1a683ac9
LBP2026-04-30T16:39:51Z41.1%+11.2pp
Network propagation: 30.0% → 41.1%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
legacy v12026-04-30T16:13:50Z30.0%-11.2pp
reference_class_assigned bayesian_v2 inside=0.600 blend=0.300 w_in=0.30 agi_breakthrough_5y
LBP2026-04-30T02:18:57Z41.1%+11.2pp
Network propagation: 30.0% → 41.1%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef
legacy v12026-04-30T01:56:50Z30.0%-30.0pp
reference_class_assigned bayesian_v2 inside=0.600 blend=0.300 w_in=0.30 agi_breakthrough_5y

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
killerTK06
China-Taiwan Military Conflict
8.0%0.0500.600+0.044
killerTK03
AI Regulatory Moratorium (EU/US Capability Freeze)
10.0%0.0500.600+0.033
killerTK11
Autonomous Regulatory Block (Level 4 Halt)
10.0%0.0500.600+0.033
killerTK01
AGI Capability Plateau (2026-27 Training Stall)
15.0%0.0500.600+0.005

Top outgoing (children)

Predictions THIS node influences

No outgoing edges.

Prerequisites (6)

Predictions that must hit first
TypePredTitleDomainLag
correlateS_AGI_MID_2029AGI mid: Kurzweil 2029 pathagi_general_capability
correlateS_AGI_SLOW_2031AGI slow: Schmidt/Hassabis 5-10 year pathagi_general_capability
killerTK01AGI Capability Plateau (2026-27 Training Stall)
killerTK03AI Regulatory Moratorium (EU/US Capability Freeze)
killerTK11Autonomous Regulatory Block (Level 4 Halt)
killerTK06China-Taiwan Military Conflict

Dependents (0)

Predictions enabled by this
TypePredTitleDomainLag
No dependents

Validations (1)

Resolution events
Observed atStatusByNotes
2026-04-29partialthesis_timeline_v1.0_importAlphaFold 3, Isomorphic Labs, Atomic AI, Cradle all accelerating biology cycles; AlphaProteo de-novo protein design 2024; GNoME materials discovery.

Linked documents (10)

Auto-generated by cosine similarity from Polymarket / Manifold / EDGAR / GDELT
SimSourceTitleMarket probPolarityReviewedPublished
0.604arxivAn explainable hypothesis-driven approach to Drug-Induced Liver Injury with HADESmentionspending2026-05-04
0.599arxivUnsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessmentmentionspending2026-06-04
0.598fdaFDA NDA219249: ITOVEBI (INAVOLISIB) — GENENTECH INCmentionspending2026-04-15
0.587fdaFDA ANDA208539: TICAGRELOR (TICAGRELOR) — MICRO LABSmentionspending2026-04-27
0.583fdaFDA ANDA215243: RAMELTEON (RAMELTEON) — MICRO LABSmentionspending2026-04-15
0.571fdaFDA ANDA219189: GALLIUM GA-68 GOZETOTIDE (GALLIUM GA-68 GOZETOTIDE) — IONETIXmentionspending2026-05-14
0.570fdaFDA ANDA218441: SITAGLIPTIN (SITAGLIPTIN) — BIOCON PHARMA LTDmentionspending2026-05-01
0.570fdaFDA ANDA090170: LAMOTRIGINE (LAMOTRIGINE) — UNICHEM LABS LTDmentionspending2026-04-09
0.563fdaFDA NDA212927: TIOCYSTIN (TIOPRONIN) — CASPER PHARMA LLCmentionspending2026-06-02
0.559fdaFDA ANDA218558: BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE) — MICRO LABSmentionspending2026-05-07

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "qty": "10-100x compression",
  "mode": "FORECAST",
  "role": "Cited-CEO",
  "context": "Sharpens Hassabis's AGI-definition (CMQ_010) and biology-compression thesis beyond 247_033 (cure all disease in decade). The '100 years of biology' phrasing is Hassabis's signature framing.",
  "to_year": 2040,
  "conv_cues": "vivid compression metaphor; AGI-definition framing",
  "direction": "HAPPEN",
  "from_year": 2030,
  "timeframe": "2030-2040",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "Isomorphic Labs files first IND for AI-designed oncology drug",
      "source": "https://www.clinicaltrialsarena.com/news/isomorphic-labs-prepares-trials-ai-designed-drugs/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -11,
      "source_id": null,
      "confidence": 0.8,
      "source_url": "https://www.clinicaltrialsarena.com/news/isomorphic-labs-prepares-trials-ai-designed-drugs/",
      "expected_date": "2026-12-15",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2027-06-30",
        "from": "2026-06-01"
      },
      "measurement_criterion": "FDA IND acceptance and ClinicalTrials.gov registration of first Isomorphic Labs-originated oncology candidate, confirming the (revised) end-2026 Davos timeline"
    },
    {
      "kind": "llm_pre_event",
      "label": "Isomorphic Labs Phase 1 first-in-human dose administered for AI-designed cancer drug",
      "source": "https://creati.ai/ai-news/2026-02-14/deepmind-ai-cancer-drug-clinical-trials-2026-demis-hassabis/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -10,
      "source_id": null,
      "confidence": 0.7,
      "source_url": "https://creati.ai/ai-news/2026-02-14/deepmind-ai-cancer-drug-clinical-trials-2026-demis-hassabis/",
      "expected_date": "2027-09-15",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2028-06-30",
        "from": "2026-12-01"
      },
      "measurement_criterion": "Isomorphic Labs press release or peer-reviewed publication confirms first patient dosed in Phase 1 trial of AI-designed (de novo molecule) oncology compound"
    },
    {
      "kind": "llm_pre_event",
      "label": "Isomorphic Labs / DeepMind reports drug discovery cycle time reduction below 12 months for at least one program",
      "source": "https://www.isomorphiclabs.com/our-tech",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -9,
      "source_id": null,
      "confidence": 0.55,
      "source_url": "https://www.isomorphiclabs.com/our-tech",
      "expected_date": "2028-07-01",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2029-12-31",
        "from": "2027-01-01"
      },
      "measurement_criterion": "Peer-reviewed publication or Isomorphic disclosure shows hit-to-IND time under 12 months (vs. industry average 4-6 years) for at least one program, demonstrating Hassabis 'weeks not years' framing in practice"
    },
    {
      "kind": "scenario_signal",
      "label": "Scenario fires: AGI mid: Kurzweil 2029 path",
      "status": "pending",
      "weight": 0.3,
      "ordinal": -8,
      "source_id": "S_AGI_MID_2029",
      "expected_date": "2029-03-31",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "First peer-reviewed publication where AI system autonomously formulates and validates a novel scientific hypothesis (no targeted prompting)",
      "source": "https://fortune.com/article/demis-hassabis-deepmind-artificial-intelligence-google-alphabet-drug-discovery-isomorphic/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.5,
      "source_url": "https://fortune.com/article/demis-hassabis-deepmind-artificial-intelligence-google-alphabet-drug-discovery-isomorphic/",
      "expected_date": "2030-03-17",
      "research_origin": "deep_research",
... (truncated)